Literature DB >> 8995800

Phylogenetic analysis of the genus Actinomyces based on 16S rRNA gene sequences: description of Arcanobacterium phocae sp. nov., Arcanobacterium bernardiae comb. nov., and Arcanobacterium pyogenes comb. nov.

C P Ramos1, G Foster, M D Collins.   

Abstract

A systematic phylogenetic analysis of the genus Actinomyces was performed. The 16S rRNA gene sequences of 13 Actinomyces species, an unnamed Actinomyces strain (ATCC 49338), and an Actinomyces-like isolate from sea mammals were determined. Comparative sequence analysis with closely related taxa revealed phylogenetic diversity and internal structure within the genus Actinomyces. In addition, some members of other genera (viz., the genera Arcanobacterium, Mobiluncus, and Rothia) were shown to be phylogenetically intermixed with the Actinomyces species. It was evident from both distance and tree topology considerations that the genus Actinomyces is in urgent need of taxonomic revision and requires subdivision into several genera. Based on the results of the present study it is proposed that Actinomyces bernardiae and Actinomyces pyogenes be assigned to the genus Arcanobacterium as Arcanobacterium bernardiae comb. nov. and Arcanobacterium pyogenes comb. nov., respectively. In addition, a new species, Arcanobacterium phocae, is proposed for Actinomyces-like bacteria isolated from seals.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8995800     DOI: 10.1099/00207713-47-1-46

Source DB:  PubMed          Journal:  Int J Syst Bacteriol        ISSN: 0020-7713


  31 in total

1.  Development of amplified 16S ribosomal DNA restriction analysis for identification of Actinomyces species and comparison with pyrolysis-mass spectrometry and conventional biochemical tests.

Authors:  V Hall; G L O'Neill; J T Magee; B I Duerden
Journal:  J Clin Microbiol       Date:  1999-07       Impact factor: 5.948

Review 2.  Bacteria and fungi of marine mammals: a review.

Authors:  R Higgins
Journal:  Can Vet J       Date:  2000-02       Impact factor: 1.008

3.  An Arcanobacterium (Actinomyces) pyogenes mutant deficient in production of the pore-forming cytolysin pyolysin has reduced virulence.

Authors:  B H Jost; J G Songer; S J Billington
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

4.  Phenotypic identification of Actinomyces and related species isolated from human sources.

Authors:  N Sarkonen; E Könönen; P Summanen; M Könönen; H Jousimies-Somer
Journal:  J Clin Microbiol       Date:  2001-11       Impact factor: 5.948

5.  Identification of clinical isolates of actinomyces species by amplified 16S ribosomal DNA restriction analysis.

Authors:  V Hall; P R Talbot; S L Stubbs; B I Duerden
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

6.  Evaluation of four commercial test systems for identification of actinomyces and some closely related species.

Authors:  Anne-Marie Santala; Nanna Sarkonen; Val Hall; Petteri Carlson; Hannele Jousimies-Somer; Eija Könönen
Journal:  J Clin Microbiol       Date:  2004-01       Impact factor: 5.948

7.  Ten cases of Actinobaculum schaalii infection: clinical relevance, bacterial identification, and antibiotic susceptibility.

Authors:  Mark Reinhard; Jørgen Prag; Michael Kemp; Keld Andresen; Belinda Klemmensen; Niels Højlyng; Susan Hildebrand Sørensen; Jens Jørgen Christensen
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

8.  Urinary tract infection due to Arcanobacterium bernardiae in a patient with a urinary tract diversion.

Authors:  J P Lepargneur; R Heller; R Soulié; P Riegel
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-06       Impact factor: 3.267

9.  Isolation of Arcanobacterium pyogenes from the porcine gastric mucosa.

Authors:  B H Jost; K W Post; J G Songer; S J Billington
Journal:  Vet Res Commun       Date:  2002-08       Impact factor: 2.459

10.  Genotypic diversity of clinical Actinomyces species: phenotype, source, and disease correlation among genospecies.

Authors:  Jill E Clarridge; Qing Zhang
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.